Tag: Valuations

Browse our exclusive articles!

Goldman deems AI stock’s 140% YTD surge as excessive

Palantir's recent stock surge is overdone, says Goldman Sachs. While AI has fuelled a demand for companies focused on the technology, the investment bank believes the rally is unjustified. Their analysts argue AI is just an extension of Palantir's existing data analytics work, not a substantial change in strategy or take-up. However, the firm still sees AI as a future tailwind, which could help drive growth. Goldman Sachs has raised Palantir's price target to $10 per share but warns that it signals a downside risk of almost 35% from current levels.

The Growing Importance of Diversity, Data, and Compliance for Venture Capitalists

Venture capitalists must focus on diversity, data, and compliance as the industry faces a crisis wave. Priorities are changing, and standardized investment score algorithms can help underrepresented founders receive funding. Startups should have a public profile, diverse workforce, and sustainable practices. Embrace data-driven approaches and prevent human biases to lead to a more robust VC asset class.

AI Stocks Predicted to Reach $20 Trillion Value by 2030

Investing in the AI giants Amazon, Alphabet, Microsoft, Nvidia, Apple, and Meta Platforms might lead to huge profits by 2030. But, beware of industry over-optimism and economic risks.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img